These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 13603108)

  • 1. [Studies on therapeutic possibilities in poisoning by radioactive cleavage products. III. Effects of late administration of diethylenetriaminepentaacetic acid on radiocerium excretion].
    CATSCH A; DU KHUONG LE
    Strahlentherapie; 1958 Oct; 107(2):298-308. PubMed ID: 13603108
    [No Abstract]   [Full Text] [Related]  

  • 2. [Distribution of radiocerium in liver cells and its modification by diethylenetriaminepentaacetic acid].
    CATSCH A; IMMEL-TELLER H; SCHINDEWOLF JORDAN D
    Z Naturforsch B; 1961 Mar; 16B():181-5. PubMed ID: 14448645
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the therapeutic possibilities in poisoning with radioactive fission products. II. Effect of diaminodiethylether tetraacetic acid and diethylenetriamine pentaacetic acid on the distribution of radiocerium].
    CATSCH A; LE DK; MELCHINGER H
    Strahlentherapie; 1958 Aug; 106(4):606-26. PubMed ID: 13580685
    [No Abstract]   [Full Text] [Related]  

  • 4. REMOVAL OF INHALED RADIOACTIVE YTTRIUM BY THE USE OF DIETHYLENETRIAMINE-PENTAACETIC ACID (DTPA).
    SCHMIDTKE I
    Health Phys; 1964 Dec; 10():1235-41. PubMed ID: 14244770
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on therapeutic possibilities in poisoning by radioactive fission products. I. Influence of chelating agents on the behavior of radiocerium in mammalian organisms].
    CATSCH A; LE DK
    Strahlentherapie; 1957 Dec; 104(4):494-506. PubMed ID: 13519328
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of repeated parenteral administration of chelating agents on the distribution and excretion of uranium.
    Domingo JL; Ortega A; Llobet JM; Paternain JL; Corbella J
    Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):161-4. PubMed ID: 2748997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of internally deposited radiocerium by the use of chelating agents.
    CATSCH A; DU KHUONG LE
    Nature; 1957 Sep; 180(4586):609. PubMed ID: 13477239
    [No Abstract]   [Full Text] [Related]  

  • 8. [Removal of radionuclides from the body. (Studies on radiocerium and diethylenetriaminepentaacetic acid)].
    CATSCH A
    Strahlentherapie; 1961 Apr; 114():565-76. PubMed ID: 13691588
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental treatment of poisoning from fission products; ability of chemical agents to alter the uptake and retention of fission products in animals exposed to radioactive fall-out.
    COHN SH; GONG JK; MILNE WL
    AMA Arch Ind Health; 1956 Dec; 14(6):533-8. PubMed ID: 13371940
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolism and toxicity of therapeutic chelating agents. I. Comparative studies on the excretion of EDTA and DTPA in the rat urine].
    Harmuth-Hoene AE
    Strahlentherapie; 1967 Sep; 134(1):110-22. PubMed ID: 4967657
    [No Abstract]   [Full Text] [Related]  

  • 11. THE METABOLISM OF BIOLOGICALLY IMPORTANT RADIONUCLIDES. VIII. SOME ASPECTS OF THE PREVENTION AND TREATMENT OF EXCESSIVE INTERNAL RADIOACTIVE CONTAMINATION.
    DUNCAN KP
    Br J Radiol; 1964 Feb; 37():120-3. PubMed ID: 14120789
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolism and toxicity of therapeutic chelating agents. X. Excretion of endogenous manganese].
    Nadolny W
    Strahlentherapie; 1971; 141(1):100-5. PubMed ID: 5002888
    [No Abstract]   [Full Text] [Related]  

  • 13. [Metabolism and toxicity of therapeutic chelating agents. 9. Metabolization of EDTA and DTPA].
    Zorn H
    Strahlentherapie; 1970 Oct; 140(4):452-9. PubMed ID: 4994945
    [No Abstract]   [Full Text] [Related]  

  • 14. Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I. Effect of labeling on distribution and excretion of radioactivity in rats.
    Staud F; Nishikawa M; Morimoto K; Takakura Y; Hashida M
    J Pharm Sci; 1999 Jun; 88(6):577-85. PubMed ID: 10350492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of the Ca-complexes of aminopolycarboxylic acids on the excretion and distribution of zinc].
    Eybl V; Sýkora J; Mertl F
    Z Gesamte Exp Med Einschl Exp Chir; 1970 Aug; 152(4):274-83. PubMed ID: 4995887
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prophylactic and therapeutic effect of various chelating agents in contamination caused by radioactive metals].
    BIANCHI C; DETTORI G
    G Med Mil; 1956; 106(2):264-74. PubMed ID: 13345028
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of chelating agents on toxicity of copper to Elsholtzia splendens].
    Li F; Xiong Z; Hu H
    Huan Jing Ke Xue; 2003 Nov; 24(6):96-100. PubMed ID: 14768573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of chelating agents for accelerating excretion of radioelements.
    FOREMAN H
    J Am Pharm Assoc Am Pharm Assoc; 1953 Oct; 42(10):629-32. PubMed ID: 13096409
    [No Abstract]   [Full Text] [Related]  

  • 19. [Accelerated excretion of intratracheally administered radiocerium by means of diethylenetriamine pentaacetic acid].
    Trnovec T; Beno M; Plesková A; Vladár M
    Cesk Hyg; 1965 Aug; 10(7):385-92. PubMed ID: 5836586
    [No Abstract]   [Full Text] [Related]  

  • 20. Excretion of yttrium and lanthanum chelates of cyclohexane 1,2-trans diamine tetraacetic acid and diethylenetriamine pentaacetic acid in man.
    KROLL H; KORMAN S; SIEGEL E; HART HE; ROSOFF B; SPENCER H; LASZLO D
    Nature; 1957 Nov; 180(4592):919-20. PubMed ID: 13483559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.